Subtype
Ovarian Sex Cord-Stromal Tumor
CI-CAN-00003551Explore in graph →
Non-malignant4 active trials11 evidence items
Loading cancer entity…
Subtype
CI-CAN-00003551Explore in graph →
Clinical trials
17 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT06169124 | Study to Test the Drug Darolutamide Along With the Drugs Leuprolide Acetate and Exemestane in Patients With Recurrent Ovarian Granulosa Cell Tumors | active not recruiting | Phase 2 | 17 | National Cancer Institute (NCI)NIH | 1 | Jul 28, 2026 | clinicaltrials |
| NCT05872204 | Abemaciclib and Letrozole in Patients With Estrogen Receptor-positive Rare Ovarian Cancer(ALEPRO) | recruiting | Phase 2 | 100 | Universitaire Ziekenhuizen KU LeuvenOTHER | 3 | May 5, 2026 | clinicaltrials |
| NCT06638931 | Agnostic Therapy in Rare Solid Tumors(ANTARES) | recruiting | Phase 2 | 28 | Instituto do Cancer do Estado de São PauloOTHER | 1 | Apr 15, 2026 | clinicaltrials |
Data updated 23 days agoSource updated Jul 28, 2026source: clinicaltrials